CXCL13: a novel biomarker of B-cell return following rituximab treatment and synovitis in patients with rheumatoid arthritis

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Evolving concepts of rheumatoid arthritis2003 · 3,637 citations
2. 2Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis2004 · 2,606 citations
3. 3Subspecialization of Cxcr5+ T Cells2001 · 622 citations
4. 4The human Ig-beta cDNA sequence, a homologue of murine B29, is identical in B cell and plasma cell lines producing all the human Ig isotypes1993 · 28 citations
5. 5B-cell differentiation following autologous, conventional, or T-cell depleted bone marrow transplantation: a recapitulation of normal B-cell ontogeny1990 · 139 citations